InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Hecht Peter M, Chief Executive Officer. Officer active across 1 companies, notably Cyclerion Therapeutics, Inc.. Aggregated, 6 filings have been recorded. Total volume traded: €6.2m. The latest transaction was disclosed on 3 June 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€2m823,170 shares@ €2.703446.04% mcap78.5% of flow
Common Stock
SEC:0001140361-21-020090·
Ideal exit: 28 Feb 2022 (T+270)
€2m823,170 shares@ €2.703446.04% mcap35.7% of flow
Common Stock
SEC:0001140361-21-020090:0·
Ideal exit: 28 Feb 2022 (T+270)
€608,076302,000 shares@ €2.013512.58% mcap21.5% of flow
Common Stock
SEC:0001140361-21-016532·
Ideal exit: 31 Jan 2022 (T+270)
€608,076302,000 shares@ €2.013512.58% mcap9.7% of flow
Common Stock
SEC:0001140361-21-016532:0·
Ideal exit: 31 Jan 2022 (T+270)
300,000 shares
Common Stock
SEC:0001140361-21-016304·
Ideal exit: 29 Jan 2022 (T+270)
€571,783300,000 shares@ €1.905911.83% mcap9.2% of flow
Common Stock
SEC:0001140361-21-016304:0·
Ideal exit: 29 Jan 2022 (T+270)
6 of 6 declarations
About Hecht Peter M
Hecht Peter M is the Chief Executive Officer of Cyclerion Therapeutics, Inc. In this role, he is responsible for the strategic direction of the company and the management of its operations. His leadership is essential in guiding the organization toward its goals, ensuring it remains competitive and innovative in the biotechnology sector.
